Eversheds Sutherland has advised Ingevity Corporation on its €590m acquisition of Warrington-based Perstorp UK Limited, the caprolactone division of the wider Perstorp Group. The transaction, which…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Paolo Bossi
…
This content is for Standard 1 Year members only. LoginJoin Now